Literature DB >> 15334692

Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR.

Jun Liu1, Ying-Hui Li, Jin Ding, Wei-Dong Gong, Cai-Fang Xue, Ya Zhao, Yu-Xiao Huang.   

Abstract

AIM: To quantify the inhibition of HBV replication by targeted ribonuclease by using real-time fluorescent PCR.
METHODS: Targeted ribonuclease was introduced into 2.2.15 cells by liposome-mediated transfection or HIV-TAT mediated protein transduction. Forty-eight hours after the transfection and 24 h after the transduction, supernatants of 2.2.15 cells were collected and HBV DNA in the supernatants was quantified by real-time fluorescent PCR with a commercial kit.
RESULTS: HBV DNA concentrations in the supernatants of 2.2.15 cells transfected or transducted with targeted ribonuclease were 4.9+/-2.4 x 10(8) copies/L and 8.3+/-4.0 x 10(8) copies/L, respectively. Compared with controls, transfection or transduction of targeted ribonuclease reduced HBV DNA concentration in the supernatants of 2.2.15 cells by 90.4% and 90.1%, respectively (P<0.05).
CONCLUSION: Targeted ribonuclease can inhibit HBV replication in 2.2.15 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334692      PMCID: PMC4572124          DOI: 10.3748/wjg.v10.i19.2883

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

Review 1.  Management of chronic hepatitis B.

Authors:  Hari S Conjeevaram; Anna Suk-Fong Lok
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Inhibition of hepatitis B virus replication by stably expressed shRNA.

Authors:  Ying Chen; Dan Du; Jun Wu; Chun-Pong Chan; Yuequi Tan; Hsiang-fu Kung; Ming-Liang He
Journal:  Biochem Biophys Res Commun       Date:  2003-11-14       Impact factor: 3.575

3.  New antiviral strategy using capsid-nuclease fusion proteins.

Authors:  G Natsoulis; J D Boeke
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

4.  Inhibition of hepatitis B virus expression and replication by RNA interference.

Authors:  Amir Shlomai; Yosef Shaul
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.

Authors:  Tatsuya Ide; Ryukichi Kumashiro; Yuriko Koga; Eisuke Tanaka; Teruko Hino; Akiko Hisamochi; Shiro Murashima; Kei Ogata; Kazuo Tanaka; Reiichiro Kuwahara; Michio Sata
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

6.  Targeted ribonuclease can inhibit replication of hepatitis B virus.

Authors:  Jun Liu; Ying-Hui Li; Cai-Fang Xue; Jin Ding; Wei-Dong Gong; Ya Zhao; Yu-Xiao Huang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.

Authors:  B Werle; K Cinquin; P Marcellin; S Pol; M Maynard; C Trépo; F Zoulim
Journal:  J Viral Hepat       Date:  2004-01       Impact factor: 3.728

8.  Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees.

Authors:  Stefan F Wieland; Hans Christian Spangenberg; Robert Thimme; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

9.  Selective inhibition of hepatitis B virus replication by RNA interference.

Authors:  Chunxiao Ying; Erik De Clercq; Johan Neyts
Journal:  Biochem Biophys Res Commun       Date:  2003-09-19       Impact factor: 3.575

10.  Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assays.

Authors:  Madoka Kohmoto; Masaru Enomoto; Yoshihisa Yano; Shuzo Otani; Shin Minamitani; Akihiro Tamori; Daiki Habu; Tadashi Takeda; Susumu Shiomi; Shuichi Seki; Tetsuo Arakawa; Shuhei Nishiguchi
Journal:  Hepatol Res       Date:  2003-06       Impact factor: 4.288

View more
  1 in total

Review 1.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.